EEF1A1 and cancer: As our understanding of eEF1A’s moonlighting functions in cancer progression deepens, novel inhibitors with improved efficacy and safety profiles may emerge, including mutation-adapted compounds, offering new hope for patients with aggressive or treatment-resistant malignancies.